Lazard Us Valuation
| RUSRX Fund | 12.13 0.02 0.17% |
Based on Macroaxis valuation methodology, the fund is fairly valued. Lazard Systematic Small secures a last-minute Real Value of USD11.93 per share. The latest price of the fund is USD12.13. Our model forecasts the value of Lazard Systematic Small from analyzing the fund technical indicators and probability of bankruptcy. In general, investors recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Fairly Valued
Today
Please note that Lazard Us' price fluctuation is very steady at this time. Based on Macroaxis valuation methodology, the fund is fairly valued. Lazard Systematic Small secures a last-minute Real Value of USD11.93 per share. The latest price of the fund is USD12.13. Our model forecasts the value of Lazard Systematic Small from analyzing the fund technical indicators and probability of bankruptcy. In general, investors recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Since Lazard Us is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lazard Mutual Fund. However, Lazard Us' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.13 | Real 11.93 | Hype 12.11 |
The intrinsic value of Lazard Us' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lazard Us' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lazard Systematic Small helps investors to forecast how Lazard mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lazard Us more accurately as focusing exclusively on Lazard Us' fundamentals will not take into account other important factors: About Lazard Us Valuation
Our relative valuation model uses a comparative analysis of Lazard Us. We calculate exposure to Lazard Us's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lazard Us's related companies.The Portfolio invests primarily in equity securities, principally common stocks, of small capitalization U.S. companies. Under normal circumstances, the Portfolio invests at least 80 percent of its assets in equity securities of small cap U.S. companies. The Portfolio may invest up to 20 percent of its assets in other securities which need not be equity securities of small cap U.S. companies, including investments in larger U.S. companies and in non-U.S. companies, including securities of emerging markets companies traded on a U.S. exchange.
Other Information on Investing in Lazard Mutual Fund
Lazard Us financial ratios help investors to determine whether Lazard Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lazard with respect to the benefits of owning Lazard Us security.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |